John W. Gillard
Publications by Year
Research Areas
Asthma and respiratory diseases, Cell death mechanisms and regulation, Bioactive Compounds and Antitumor Agents, Oxidative Organic Chemistry Reactions, Synthesis and Biological Evaluation
Most-Cited Works
- → cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination(2008)1,077 cited
- → Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis(1990)776 cited
- → Identification and isolation of a membrane protein necessary for leukotriene production(1990)462 cited
- → L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor(1989)328 cited
- → MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.(1990)316 cited
- → Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.(1990)189 cited
- → Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis(2006)129 cited
- → Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor(1992)113 cited
- → The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic Agents(1999)97 cited
- → Trimethylsilyl bromide as a mild, stereoselective anomeric brominating agent(1981)69 cited